About this podcast
Life sciences, under the hood. Deep dives into the patent filings, regulatory gauntlets, and capital-risks that shape the business of biology.
Episodes
- Allergan: Botox, Rogue Scientists, and the Ultimate Beauty Franchise · 3 h 36 min · Episode 5The wild story of how a Cold War bioweapon became Botox — and how Allergan turned a sleepy ophthalmology drug into an enduring aesthetic franchise. Every part of this story looks…
- What is Approved? · 3 minApproved tells the definitive stories behind the world's most interesting biotech ventures. Most people learn about the industry in a fragmented, ad hoc way-- an industry article…
- Blueprint Medicines: Chasing Gleevec to a $9B Allergy Drug · 2 h 29 min · Episode 4Blueprint Medicines was built to find the next Gleevec-style cancer drug. It ended up pivoting to allergic disease instead, and selling to Sanofi for $9B. This is the platform…
- Keytruda: How Merck's Pembrolizumab Became the Best-Selling Cancer Drug of All Time · 2 h 7 min · Episode 3Keytruda is Merck's $31 billion a year PD-1 inhibitor and the best-selling cancer drug of all time. In Episode 3 of Approved, Alex Kesin and Matthew Pech trace the development of…
- Episode #2: Geron · 2 h 22 min · Episode 2Listen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:01:19) - Hayflick Limit (00:08:30) - Michael West & Founding of Geron…
- Episode #1: Amylin Pharmaceuticals · 1 h 46 min · Episode 1Listen on Spotify Listen on Apple Podcasts Listen on YouTube TABLE OF CONTENTS (00:00:00) - Introduction (00:04:40) - $50 of Dried Lizard Venom (00:29:17) - Fax of Death…







